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Abstract 
The present study is targeted to formulate and prepare effervescent tablets of Glipizide to provide more elegancy, 
comfortability, and improved pharmacokinetics in diabetic treatment than the conventional dosage. Three 
formulations (F1, F2, and F3) of the effervescent tablet of Glipizide (5mg) were formulated with different amounts 
and ratios of excipients. By wet granulation technique, 60 tablets for every formulation were prepared with a 
weight of 700mg per tablet. Then, the features of both granules and tablets were evaluated by published methods. 
The angle of repose, Hausner ratio, Carr's index, Loss on drying (LOD), and Moisture Content (MC) used to 
measure granules property successfully proved right follow ability and compressibility. In contrast, physical and 
drug content related investigation failed to determine the perfectness of all three formulations. Friability on the 
formulations was around 0.70%, indicating the expected USP limit of friability (0.5 to 1%). The mean 
disintegration time of the formulations was from 95s to 105s. The tablet potency assay found 95.20% for F1, 88.80% 
for F2, and 97.40% for F3. The dissolution pattern of the drug followed a linear relationship with time. After one 
and a half hours, the highest amount of 59.20% cumulative dissolution was determined for F3 that revealed its 
strategic improvement of the drug solubility. As Glipizide is a poorly water-soluble drug, the effervescent tablet 
might mitigate disintegration and dissolution-related limitations and, consequently, enhance the drug's 
bioavailability. 
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1. Introduction 
Effervescent tablets offer both qualities of solid and liquid dosage forms. The tablets are dispersed and dissolved 
in water and administrate as a liquid. It presents the drug as a palatable liquid form; nevertheless, it retains the 
advantage of a solid dosage form such as dose accuracy, long stability, and easy portability (Khan et al., 2014; 
Mohammed et al., 2016). This dosage form is becoming increasingly popular due to the ease of consumption. The 
buoyant delivery system is designed to break in contact with water, often causing the tablet into an effervescent 
solution (Agyilirah et al., 1991; Saleh SI et al., 1988). However, the dosage types face many important parameters 
during manufacturing and storage. Due to premature effervescent reaction, Effervescent tablets are sensitive to 
chemical stability. The ingredients used are extensively hygroscopic. Furthermore, the presence of a trace amount 
of water commences to a self-propagating reaction and continues until a complete deterioration of the product's 
quality (Harald, 2003). So, the preparation procedures should be carried out in a controlled environment for 
humidity and temperature (Khan et al., 2014; Josep et al., 2011; Osei-Yeboah et al., 2014). 
Glipizide, a second-generation anti-diabetic drug under sulfonylurea class, is used to treat type II diabetes (Patel 
et al., 2005). Patients with type II diabetes have multiple defects like excessive hepatic glucose production, 
inadequate insulin secretion, and insulin resistance, leading to mild to severe hyperglycemia (Nauck et al., 2007). 
Glipizide depolarizes pancreatic beta cells by partially blocking the potassium channels of the cells of islets of 
Langerhans, which results in the voltage-gated calcium channels' opening and consequently enhances the calcium 
influx into the cells (Abdelmoneim AS et al. 2012). The influx encourages beta cells to release insulin (Bösenberg 
and Van Zyl, 2008). According to the Biopharmaceutics Classification System (BCS), Glipizide is a Class II drug 
that means its limitation of absorption is limited by dissolution in the gastrointestinal tube, and thus in vivo oral 
absorption and bioavailability (Jamzad and Fassihi, 2006; Verma RK. and Garg S. 2005; Tsume Y et al., 2012). 
Earlier studies indicate the facilitation of in vitro and thus oral bioavailability in vivo Glipizide by various 
techniques, including reducing particles, strong dispersion, and cyclodextrin complexation (Agrawal AG et al., 
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2015 and Isaac J et al. 2013). Patients treated with the drug are suggested to take one or two doses daily, and the 
recommended maximum amount is up to 20mg (Östman et al., 1982). Again, Clinical studies have shown that the 
absorption of Glipizide in vivo is dependent on the formulation. 
Diabetes is a chronic disease, so its treatment pattern and medication should be comfortable and elegant with daily 
lifestyle. Furthermore, Solid dosage forms are not always swallowable for geriatric and pediatric patients 
(Lieberman et al., 2009). For bed-restricted patients, the problem seems more severe (Aslani and Jahangiri, 2013). 
The formulation development study targeted to minimize the limitations of drug dissolution in gastrointestinal 
tracts and make an elegant dosage form to adhere to the patients for better patient compliance and bioavailability 
profile during the prolonged anti-diabetic medication.  
2. Materials and Methods 
a. Chemicals and reagents: 
Glipizide (gift sample from Beximco Pharma Ltd., Bangladesh), Polyvinylpyrrolidone K30 (Merck, Germany), 
Corn Starch (Merck, India), Sodium bicarbonate (LOBA Chemie, India), Citric acid, Ascorbic acid (Merck, India), 
Sodium Saccharine (HCT, China), Lactose (BDH, England), Magnesium stearate (Merck, Germany), Sodium 
Metabisulphite (Merck, India), Congo red (BDH, England). All the reagents were purchased through RFQ from 
local Suppliers.  
b. Tablet formulation 
Three formulations of Glipizide 5mg tablet named F1, F2, and F3 were calculated with different proportions of 
excipients and made a total of 700mg weight, as described in Table-1. The formulation study was conducted in 
the Pharmaceutical Technology Laboratory at the Department of Pharmacy, Noakhali Science and Technology 
University.  
 
Table 1. Formulations of Glipizide 5 mg Effervescent tablet.  
Ingredients Formulations 
F1(mg) F2 (mg) F3 (mg) 
Glipizide 5 5 5 
Polyvinylpyrrolidone K30 (PVP K30) (Binder) 100 95 90 
Corn Starch (Binder and Disintegrating agent) 115 125 135 
Sodium bicarbonate (Base and effervescent agent) 140 130 120 
Citric acid (Acidifier) 40 35 30 
Ascorbic acid (Acidifier) 50 45 40 
Sodium Saccharine (Sweetener) 5.5 6 5 
Lactose (Diluent) 226 243 260 
Magnesium stearate (Lubricant) 14 12 10 
Sodium Metabisulphite (Stabilizer) 3.5 3 4 
Congo red cool (Coloring agent) 1 1 1 
Raspberry flavor (drop) 1 1 1 
Water (ml) 0.5 0.5 0.5 
Total wt. 700 700 700 
 
c. Tablet preparation 
For every formulation, 60 tablets were prepared by the wet granulation method described by Kristensen and 
Schaefer, 1987, with a little bit of modification. Firstly, citric acid, saccharine, and ascorbic acid were ground and 
mixed by mortar and pestle. Then, Glipizide mix with the mixture. The mixture was further added to the slurry 
made from warm water, Polyvinylpyrrolidone (PVP), and 4/5 starch of the formulation. Then, the wet mass dried 
for 1 hour at 80⁰C. The dried hard mass was further ground and made a granule size passable for 60 mesh size. 
Then Saccharine, 1/5 starch, sodium metabisulphite, sodium bicarbonate, and magnesium stearate and the granules 
mixed evenly to form final powder subjected to compression with 13 mm flat punches of 15 tons Manual Hydraulic 
Pellet Press. 10.05-ton pressure was applied during tablet compression. 
d. The angle of repose (θ) measurement 
A resting angle is the highest possible angle between the powder pile's surface and the horizontal plane. It is 
indicative of the flow properties and friction force of the loose powder (Nelson, 1955; Thoke et al., 2013). 
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θ = tan-1 (H/R) 
 θ, the angle of repose; H, the height of pile; R, the radius of the base of the pile  
e. Hausner's ratio 
Hausner found that the ratio of tapped density/bulk density related to interparticle friction could be used to predict 
powder flow properties (Ashish et al., 2011). TheHausner's ratio was calculated by the formula as given below:  
Hausner’s ratio = Tapped density / Bulk density = Df/Do  
f. Carr's Index 
The indirect method of measuring powder flow from bulk densities, also known as percentage compressibility. 
Carr's index of each formulation was calculated according to the equation described by Bhowmik et al., 2009, 
given below: 
Carr’s index = [(Df - Do) /Df] × 100 
Where, Do = bulk density; Df = Tapped density 
g. Loss on drying: LOD determination 
Powder equivalent to ten tablets was dried for 4 hours in a desiccator containing silica gel. LOD was calculated as 
(Rajashree et al., 2010) 
 LOD = [ (Wi - Wf) / Wi ]×100% 
Where Wi and Wf are the initial and final weights of the granules, respectively. 
h. Moisture content (MC) determination 
The percent moisture content was calculated using the equation. (Rajashree et al., 2010) 
Moisture Content = [ (Wi - Wf) / Wf ]×100% 
Where Wi and Wf are the initial and final weights of the granules, respectively. 
i. Organoleptic properties (color, smell, taste) test 
Ten healthy volunteers were taken for each formulation to test the color, smell, and taste of the 200ml solution of 
one effervescent tablet. Informed consent was taken from the volunteers about the test procedure. Color and smell 
tests were conducted on the nominal terms- Bad, moderate, Good, pleasant. Furthermore, for taste, comments are 
recorded on Bitter, sour, sour & sweet, Sweet. 
j. Tablet hardness measurement 
Monsanto Hardness Tester measured the hardness of the tablet of each formulation. Hardness or tablet crushing 
strength is the force required to break a tablet, measured for 10 tablets per formulation in kg. 
Hardness average = Total hardness of all tablets / No. of tablets 
k. Tablet thickness and diameter determination 
The thickness and diameter of ten tablets for each formulation were evaluated using a calibrated dial caliper 
described by Srinath et al., 2011. 
l. Weight variation determination 
Twenty tablets were taken randomly for each formulation. Then, tablets individually measured the weight of tablets, 
and each tablet's deviation from the average weight was calculated (Thoke et al., 2013). 
m. Friability (F) test 
Roche friabilator was used to assess the friability of the tablet. 10 pre-weighed tablets for each formulation were 
placed in the friabilator and were subjected to the 100 revolutions. Tables have been polished using a soft muslin 
cloth and measured. The formula gives the friability (F) 
F = [ (Wi - Wf ) / Wi ] ×100 
Where Wi and Wf are the initial and final weights of the tablets, respectively. 
n. Measurement of effervescence time 
In a beaker of 200 ml filtered water was placed a single tablet at 20 °C ± 1°. When a clear solution without particles 
is obtained, effervescence time has been recorded using a stopwatch. The average of five dimensions was 
calculated to compare the formulations for each formulation. 
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o. Determination of effervescent solution pH 
The solution's pH was determined using the pH meter (HI 2211, HANNA) mentioned by Aslani and Fattahi, 2013, 
after complete dissolution in 200 ml of purified water at 20 ± 1 ° C, immediately after each tablet was dissolved. 
p. Tablet's potency determination 
The potency of tablets was determined using a UV spectrophotometer ((Shimadzu UV-1800 spectrophotometer, 
Shimadzu, Japan) at λmax = 270 nm as described by Banik et al., 2015.  
q. Preparation of standard curve 
Glipizide's mother solution was prepared to dissolve in water with a concentration of 10 mg/ml. This mother 
solution was diluted serially and made the following concentrations 1mg/ml, 0.2 mg/ml, 0.06 mg/ml, 0.024 mg/ml 
and 0.012 mg/ml. The absorbance was then recorded at a wavelength of 270 nm by a UV spectrophotometer 
according to the method given by Banik et al., 2015. 
r. Dissolution Studies 
The release rate of glipizide tablet was determined using USP Dissolution Testing Apparatus II (Paddle type). At 
37±0.5oC, 900 ml of phosphate buffer pH 6.8 was used as a dissolution medium. The paddle speed was set at 50 
rpm throughout the study. Five ml of samples were withdrawn at the time interval of 5, 15, 30, 45, 60, and 90 
minutes with the replacement of fresh 5ml medium. The withdrawn 5ml was subjected to 2 times dilution before 
taking the absorbance. The samples' absorbance was recorded by UV spectroscopy at 270 nm using phosphate 
buffer pH 6.8 as blank. The raw data have been analyzed to identify the quantity and percentage of cumulative 
drugs released at these times. 
3. Results 
The study highlights the three steps of quality assurance. Firstly, the study focused on granules characterization, 
which determines the flow of property, adhesiveness, and compressibility. Secondly, it was the characterization of 
tablets' physical nature, and the last one was on drug content-related parameters. 
 
Table 2. Features of the tablet granules of the formulations (F1, F2, and F3) 
Granules parameter F1 F2 F3 
Angle of Repose 23.12⁰  27.24⁰  25.24⁰ 
Hausner ratio 1.16 1.16 1.17 
Carrʼs index 14.325%  14.324%  14.931% 
Loss on Drying 1.06512%  1.2832%  1.2832% 
Moisture Content 1.08516%  1.3004%  1.3004% 
 
The angle of repose of F1 was the least, and the angle for all formulation is less than 30º. Hausner ratio and carr's 
index for the formulations were almost the same. F3 showed a little bit of variation from the other two. Values of 
Loss on drying and Moisture content for F3 were smaller than the others in both cases. Whereas the LOD values 
for F2 and F3 were the same and the same on MC. The features of granules property are represented in table -2. 
 
Table 3. Physical parameters of tablets of the three formulations (F1, F2, and F3)  
Tablets parameter F1 F2 F3 
Colour (Mode) Pleasant Pleasant Pleasant 
Smell (Mode) Pleasant Pleasant Pleasant 
Taste (Mode) Sour Sour & Sweet Sour 
Thickness (mean in mm) 4.05 ± 0.01 4.08 ± 0.02 4.05± 0.01 
Diameter (mean in mm) 13 ± 0 13 ± 0 13 ± 0 
Weight variation (mg) 701.35 ± 9.931 703.80 ± 16.732  705.80 ± 9.217 
Hardness (mean in Kg) 2.05 ± 0.093  2.61 ± 0.086 2.65 ± 0.203 
Friability  0.71% 0.73% 0.69% 
Disintegration time (mean in seconds) 105 90 100 
pH of the effervescent solution 7.0±0.02 7.0±0.02 7.0±0.02 
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The model on the volunteers' comment on the color and smell of three formulations was the same, but the mode 
of taste for F2 was sour and sweet, whereas, for F1 and F3, it was sour. The mean thickness of F1 and F2 was 4.05 
mm, and the mean of F2 was 4.08. The mean diameter of the formulations was 13. The highest mean weight of 20 
tablets was for F3, but the standard deviation was the highest for F2. The mean hardness of F1 and F3 was around 
2.60 kg, but the hardness of F1 was 2.05 kg. The formulations showed a friability of around 0.7%. However, the 
mean disintegration time showed few deviations depending on the formulation. This time of F1, F2, and F3 was 
105s, 90s, and 100s. The last physical parameter was to determine the pH of the effervescent solution. In all of the 
cases, the values were 7.0 ±02. The physical parameter of different formulations of Glipizide 5mg tablets are 
represented in Tabe-3.  
 
Figure 1. The potency of effervescent tablets for the three formulations 
 
The highest potency, 97.4%, was explored by F3 among the three formulations, as mentioned in Fig 1. Moreover, 
the lowest potency was found for F2, with a value of 88.8%. According to Fig 2, the regression line was very close 
to 1, indicating the linear relationship of absorbance with concentrations. 
 
Figure 2. Standard Dose-response curve of Glipizide plotting absorbance against concentration. 
 
 
Figure 3. The cumulative percentage of drug dissolution from the tablets of the three formulations with different 
time intervals 







0 0.05 0.1 0.15 0.2 0.25
Standard Curve of Glipizide
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The extent of drug dissolution increased with time for the formulations, as mentioned in Fig 3. The count started 
from 5 minutes of analysis and ran up to 90 minutes. At 5 minutes, only F3 showed dissolution near 15%. In the 
last point of time, the cumulative amounts of the dissolved drug for F1, F2, and F3 were 48.8%, 52.01%, and 
59.26%, respectively. F1 showed the minimum values at the most points in time, whereas F3 exhibit the highest 
cumulative dissolution among the three.  
4. Discussions 
Most of the oral conventional tablets and capsules are formulated to be chewed or swallowed. Despite the 
attractiveness of effervescent dosage forms, 5 mg of Glipizide effervescent tablet is not available. Since the drug 
is poorly water-soluble and has better tolerability by patients, we decided to formulate three effervescent tablets. 
The repose angles of all three formulations were smaller than 30, which means the 'very free-flowing' nature of 
the granules (Al-Hashemi et al., 2018). Hausner ratio 1.12-1.18 and Carrs index 11-15 indicate the excellent flow 
of powder material (Kaleem et al., 2020). The values of both tests for the formulations covered the rages. So, the 
prepared granules carry the nature of suitable flow property, but we cannot say it excellent. Furthermore, moisture 
content below 2.5% proves the free-flowing nature of granules (Thapa et al., 2017). So, the prepared granules' 
LOD and MC were maintained around 1.3% to adjust flow property and reducing the risk of moisture absorption 
by hygroscopic excipients (ascorbic acid, citric acid) used in tablet formulation. 
The effervescent solution's color and flavor depend on the amount and types of coloring and flavoring agents. 
Even there should have an adjustment of color with flavor. The reddish solution with raspberry favor in a specific 
concentration for formulations proved pleasant to the volunteer. The effervescent solution's tastes were determined 
by the acids, base, and sweetening agent used in the formulations. Formulation F2 tasted sour and sweet, which 
may be better than the other two formulations' sour test. Though the formulations' hardness was less than 3, the 
determined friability was less than 1%. 
What is more, the effervescent time and effervescent solution pH of all formulations were reasonably acceptable 
for the dosage form (Aslani and Jahangiri, 2013). F1 showed the least hardness. This may happen to use a more 
disintegrating agent (Corn starch) and lubricating substance (Magnesium stearate) than the others. However, the 
MC and LOD of F1 were lower than the others; it might affect hardness. 
Assay on drug content in tablets, F2 failed to meet the USP and BP specifications, it may reason behind its more 
considerable weight variability. The other two formulations are successful in passing the USP specification under 
the range (90%-100%). After confirmation of dose-response relation with UV absorbance, the drug release pattern 
was conducted. Glipizide is a poorly water-soluble drug, so the dissolution of the drug into assay media was 
probable to be very low. After one and a half hours, F3 exhibited the highest cumulative value of dissolution with 
59.2%. The least amount of binder PVP in F3 might contribute to its maximum drug release. The releases and 
dissolution of the drug from the three formulations were more than conventional tablets and the floating 
effervescent tablets (Nanjwade et al., 2012; Ramabargavi et al., 2013). Despite it raises a question, is there any 
real therapeutic advantage over other conventional glipizide tablets? Effervescent dosage release starts with a 
physical breakdown of the whole dosage form. Although molecular interaction of the drug with water is negligible, 
drug molecules turn to a media dispersion system. This dispersion may cause better dissolution and absorption, 
having high permeability through the biological membrane (Jamzad and Fassihi, 2006). This study has successfully 
developed an effervescent tablet of Glipizide 5 mg that can disintegrate within two minutes, highly elegant to the 
patient with its taste and appearance, and meet other tableting parameters. Patients can quickly adopt this 
formulation for prolonged anti-diabetic therapy.  
5. Conclusions 
The study explored the substantial relationship between compositions and results on the test parameters. 
Effervescent tablets offer attractive aesthetic values and enhance the bioavailability of drugs when compared to 
conventional tablets. This effervescent formulation will be a more attractive option for diabetic patients, especially 
for patients with prolonged anti-diabetic therapy, and pharmaceutical companies worldwide can adopt this 
formulation after a successful bioequivalence study to evaluate the effectiveness of the prepared effervescent 
tablets. 
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